-
Something wrong with this record ?
Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like THP-1 cells
P. Kollar, V. Závalová, J. Hošek, P. Havelka, T. Sopuch, M. Karpíšek, D. Třetinová, P. Suchý
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Leukemia, Monocytic, Acute MeSH
- Cell Growth Processes drug effects MeSH
- Cellulose analogs & derivatives pharmacology MeSH
- Wound Healing drug effects immunology MeSH
- Humans MeSH
- Lipopolysaccharides pharmacology MeSH
- Macrophages drug effects immunology MeSH
- Cell Line, Tumor MeSH
- Tumor Necrosis Factor-alpha biosynthesis genetics MeSH
- Tristetraprolin biosynthesis genetics MeSH
- Inflammation drug therapy immunology pathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The cytotoxicity and in vitro effects of six variously modified types of cellulose (OC--oxidized cellulose, NaOC--oxidized cellulose sodium salt, DAC--dialdehyde cellulose, CMC--carboxymethyl cellulose, MFC--microfibrilated cellulose, and MCC--microcrystalline cellulose) on the inflammatory response in macrophage-like THP-1 cells were examined, with special focus on their ability to influence gene expression and the production of TNF-α. The study provides evidence that DAC exerts a marked effect on the induction of TNF-α gene expression and its subsequent production in human macrophages. Thus, the use of DAC for anti-hemorrhagic or wound-healing therapy should be considered carefully with regard to its pro-inflammatory activity. On the contrary, MCC showed significant anti-inflammatory effects in the LPS-induced conditions, which might be beneficial for the treatment of non-healing chronic wounds, e.g., diabetic or venous ulcers.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022312
- 003
- CZ-PrNML
- 005
- 20160405160849.0
- 007
- ta
- 008
- 120806s2011 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.intimp.2011.02.016 $2 doi
- 035 __
- $a (PubMed)21354485
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kollár, Peter $7 xx0106036 $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic. kollarp@vfu.cz
- 245 10
- $a Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like THP-1 cells / $c P. Kollar, V. Závalová, J. Hošek, P. Havelka, T. Sopuch, M. Karpíšek, D. Třetinová, P. Suchý
- 520 9_
- $a The cytotoxicity and in vitro effects of six variously modified types of cellulose (OC--oxidized cellulose, NaOC--oxidized cellulose sodium salt, DAC--dialdehyde cellulose, CMC--carboxymethyl cellulose, MFC--microfibrilated cellulose, and MCC--microcrystalline cellulose) on the inflammatory response in macrophage-like THP-1 cells were examined, with special focus on their ability to influence gene expression and the production of TNF-α. The study provides evidence that DAC exerts a marked effect on the induction of TNF-α gene expression and its subsequent production in human macrophages. Thus, the use of DAC for anti-hemorrhagic or wound-healing therapy should be considered carefully with regard to its pro-inflammatory activity. On the contrary, MCC showed significant anti-inflammatory effects in the LPS-induced conditions, which might be beneficial for the treatment of non-healing chronic wounds, e.g., diabetic or venous ulcers.
- 650 _2
- $a buňky - růstové procesy $x účinky léků $7 D048708
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a celulosa $x analogy a deriváty $x farmakologie $7 D002482
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $x farmakoterapie $x imunologie $x patologie $7 D007249
- 650 _2
- $a akutní monocytární leukemie $7 D007948
- 650 _2
- $a lipopolysacharidy $x farmakologie $7 D008070
- 650 _2
- $a makrofágy $x účinky léků $x imunologie $7 D008264
- 650 _2
- $a tristetraprolin $x biosyntéza $x genetika $7 D051816
- 650 _2
- $a TNF-alfa $x biosyntéza $x genetika $7 D014409
- 650 _2
- $a hojení ran $x účinky léků $x imunologie $7 D014945
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Závalová, Veronika $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 700 1_
- $a Hošek, Jan $7 xx0106185 $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 700 1_
- $a Havelka, Pavel $7 _BN002434 $u VUOS a.s., Rybitví 296, CZ-533 54 Rybitví, Czech Republic
- 700 1_
- $a Sopuch, Tomáš $7 xx0140706 $u Synthesia, a.s., Pardubice – Semtín 103, CZ-532 17 Pardubice, Czech Republic
- 700 1_
- $a Karpíšek, Michal $7 xx0107472 $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 700 1_
- $a Třetinová, Dominika $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 700 1_
- $a Suchý, Pavel, $d 1970- $7 mzk2008448769 $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 773 0_
- $w MED00006034 $t International immunopharmacology $x 1878-1705 $g Roč. 11, č. 8 (2011), s. 997-1001
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21354485 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20160405160925 $b ABA008
- 999 __
- $a ok $b bmc $g 944225 $s 779609
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 11 $c 8 $d 997-1001 $e 20110226 $i 1878-1705 $m International immunopharmacology $n Int Immunopharmacol $x MED00006034
- LZP __
- $b NLK111 $a Pubmed-20120806/12/01